Text Modules

Share

Program Content

Activities

  • HER2 ADCs: GU Malignancies
    Emerging HER2-Targeted Antibody–Drug Conjugates in Genitourinary Malignancies
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 08, 2024

    Expires: October 07, 2024

  • HER2 Targeted ADCs: GI Cancers
    Emerging HER2-Targeted Antibody Drug Conjugates in Gastrointestinal Malignancies
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 09, 2024

    Expires: October 08, 2024

  • HER2 ADCs in Gynecologic Cancers
    Emerging HER2-Targeted Antibody–Drug Conjugates in Gynecologic Cancers
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 09, 2024

    Expires: November 08, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.